PDK1 Inhibitor BX795 Improves Cisplatin and Radio-Efficacy in Oral Squamous Cell Carcinoma by Downregulating the PDK1/CD47/Akt-Mediated Glycolysis Signaling Pathway

S.Balakrishna Pai(St. Martin de Porres Hospital), Jo-Ting Tsai(Taipei Medical University-Shuang Ho Hospital)
International Journal of Molecular Sciences
October 25, 2021
Cited by 77


Related Papers